CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, M. S.
Right arrow Articles by Spirtas, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, M. S.
Right arrow Articles by Spirtas, R.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 1574-1578, December 2002
© 2002 American Association for Cancer Research

Do Thyroid Disorders Increase the Risk of Breast Cancer?1

Michael S. Simon2, Mei-Tzu C. Tang, Leslie Bernstein, Sandra A. Norman, Linda Weiss3, Ronald T. Burkman, Janet R. Daling, Dennis Deapen, Suzanne G. Folger, Kathi Malone, Polly A. Marchbanks, Jill A. McDonald, Brian L. Strom, Hoyt G. Wilson and Robert Spirtas

Divisions of Hematology and Oncology [M. S. S.] and Epidemiology [L. W.], Karmanos Cancer Institute at Wayne State University, Detroit, Michigan; Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington [M-T. C. T., J. R. D., K. M.]; Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California [L. B., D. D.]; Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania [S. A. N., B. L. S.]; Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts [R. T. B.]; University of Washington, School of Public Health and Community Medicine, Department of Epidemiology, Seattle, Washington [J. R. D., K. M.]; Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia [S. G. F., P. A. M., J. A. M., H. G. W.]; and Contraception and Reproductive Health Branch, Center for Population Research, National Institute of Child Health and Human Development, Bethesda, Maryland [R. S.]

The objective of this study was to determine whether thyroid disorders or treatment of such disorders affects the risk of breast cancer. Subjects aged 35–64 years were participants in the National Institute of Child Health and Human Development Women’s Contraceptive and Reproductive Experiences Study, a population-based, case-control study of invasive breast cancer that was carried out at five sites in the United States. In-person interviews were completed for 4575 women (cases) with breast cancer (2953 white and 1622 black) and 4682 control women (3021 white and 1661 black). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using multiple logistic regression methods. Models included adjustment for age (5-year age groups), race (white or black), and site. A history of any thyroid disorder (OR = 1.1, 95% CI = 0.9–1.2) was not associated with breast cancer risk. Only women with a history of thyroid cancer had an increased risk, but this was restricted to parous women (parous OR = 3.4, 95% CI = 1.5–8.1; nulliparous OR = 0.5, 95% CI = 0.04–5.1). Breast cancer risk was not associated with treatment for thyroid disorders. There was no statistical interaction between thyroid disorders, thyroid treatments, and race, menopausal status, or parity. We found no association between thyroid disorders or their associated treatments and the risk of breast cancer.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
R. B T Verkooijen, J. W A Smit, J. A Romijn, and M. P M Stokkel
The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer
Eur. J. Endocrinol., December 1, 2006; 155(6): 801 - 806.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. A. Roubidoux, J. S. Kaur, K. A. Griffith, B. Stillwater, P. Novotny, and J. Sloan
Relationship of Mammographic Parenchymal Patterns to Breast Cancer Risk Factors and Smoking in Alaska Native Women
Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1081 - 1086.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Altieri, A. Tavani, S. Gallus, C. Bosetti, R. Talamini, S. Franceschi, F. Levi, C. La Vecchia, M. S. Simon, and M.-T. C. Tang
Correspondence re: Simon et al., Do Thyroid Disorders Increase the Risk of Breast Cancer? 11: 1574-1578, 2002
Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 684 - 686.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.